Published in Cancer Weekly, January 11th, 2005
Dr. David McCready of Princess Margaret Hospital in Toronto reported on a study in which women over the age of 50 with low-risk breast cancer were randomly assigned to two treatment groups. One group received tamoxifen for 5 years after lumpectomy surgery; the other group received full breast irradiation after surgery followed by tamoxifen for 5 years.
The current treatment standard recommended for most women with early stage breast cancer is breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.